ADVERUM Canadian Trademark Information

Pharmaceutical preparations comprising recombinant adeno-associated virus for use in gene therapy for the treatment in humans of osteoarthritis, neurologic conditions, inflammatory conditions, immune-mediated conditions, endocrine diseases, chronic degenerative diseases, gastrointestinal diseases; Pharmaceutical preparations comprising recombinant adeno-associated virus for gene therapy for the treatment in humans of genetic diseases or disorders; Pharmaceutical preparations comprising recombinant adeno-associated virus for use in the treatment in humans of gene therapy treatable diseases, namely, osteoarthritis, neurologic conditions, inflammatory conditions, immune-mediated conditions, endocrine diseases, chronic degenerative diseases, gastrointestinal diseases; Pharmaceutical preparations comprising recombinant adeno-associated virus for the treatment in humans of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the ocular and auditory systems, and the genitourinary system. Pharmaceutical preparations including pharmaceutical preparations for the treatment of diseases or disorders. P...

Perfect for these industries

Pharmaceutical Products

Words that describe this mark

pharmaceutical preparations comprising recombinant adenoassociated virus use gene therapy treatment humans osteoarthritis neurologic conditions inflammatory conditions immunemediated conditions endocrine diseases chronic degenerative diseases gastrointestinal diseases pharmaceutical preparations comprising recombinant adenoassociated virus

On Monday, July 25, 2016, a canadian trademark registration was filed for ADVERUM by Adverum Biotechnologies, Inc., *********, **********, ***** ****. The Canadian IP office has given the trademark application number of 1793092. The current status of this trademark filing is Registration published. The ADVERUM trademark is filed in the description of Pharmaceutical preparations comprising recombinant adeno-associated virus for use in gene therapy for the treatment in humans of osteoarthritis, neurologic conditions, inflammatory conditions, immune-mediated conditions, endocrine diseases, chronic degenerative diseases, gastrointestinal diseases; Pharmaceutical preparations comprising recombinant adeno-associated virus for gene therapy for the treatment in humans of genetic diseases or disorders; Pharmaceutical preparations comprising recombinant adeno-associated virus for use in the treatment in humans of gene therapy treatable diseases, namely, osteoarthritis, neurologic conditions, inflammatory conditions, immune-mediated conditions, endocrine diseases, chronic degenerative diseases, gastrointestinal diseases; Pharmaceutical preparations comprising recombinant adeno-associated virus for the treatment in humans of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the ocular and auditory systems, and the genitourinary system. , Pharmaceutical preparations including pharmaceutical preparations for the treatment of diseases or disorders. , Pharmaceutical preparations for use in gene therapy for the treatment in humans of osteoarthritis, neurologic conditions, inflammatory conditions, immune-mediated conditions, endocrine diseases, chronic degenerative diseases, gastrointestinal diseases; Pharmaceutical preparations for gene therapy for the treatment in humans of genetic diseases or disorders; Pharmaceutical preparations for use in the treatment in humans of gene therapy treatable diseases, namely, osteoarthritis, neurologic conditions, inflammatory conditions, immune-mediated conditions, endocrine diseases, chronic degenerative diseases, gastrointestinal diseases; pharmaceutical preparations for the treatment in humans of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the ocular and auditory systems, and the genitourinary system. , Pharmaceutical preparations for use in gene therapy for the treatment in humans of osteoarthritis, neurologic conditions, inflammatory conditions, immune-mediated conditions, endocrine diseases, chronic degenerative diseases, gastrointestinal diseases; Pharmaceutical preparations for gene therapy for the treatment in humans of genetic diseases or disorders; Pharmaceutical preparations for use in the treatment in humans of gene therapy treatable diseases, namely, osteoarthritis, neurologic conditions, inflammatory conditions, immune-mediated conditions, endocrine diseases, chronic degenerative diseases, gastrointestinal diseases; pharmaceutical preparations for the treatment in humans of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the ocular and auditory systems, and the genitourinary system. , Pharmaceutical preparations including pharmaceutical preparations for the treatment of diseases or disorders. , Pharmaceutical preparations comprising recombinant adeno-associated virus for use in gene therapy for the treatment in humans of osteoarthritis, neurologic conditions, inflammatory conditions, immune-mediated conditions, endocrine diseases, chronic degenerative diseases, gastrointestinal diseases; Pharmaceutical preparations comprising recombinant adeno-associated virus for gene therapy for the treatment in humans of genetic diseases or disorders; Pharmaceutical preparations comprising recombinant adeno-associated virus for use in the treatment in humans of gene therapy treatable diseases, namely, osteoarthritis, neurologic conditions, inflammatory conditions, immune-mediated conditions, endocrine diseases, chronic degenerative diseases, gastrointestinal diseases; Pharmaceutical preparations comprising recombinant adeno-associated virus for the treatment in humans of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the ocular and auditory systems, and the genitourinary system. , Pharmaceutical preparations comprising recombinant adeno-associated virus for use in gene therapy for the treatment in humans of osteoarthritis, neurologic conditions, inflammatory conditions, immune-mediated conditions, endocrine diseases, chronic degenerative diseases, gastrointestinal diseases; Pharmaceutical preparations comprising recombinant adeno-associated virus for gene therapy for the treatment in humans of genetic diseases or disorders; Pharmaceutical preparations comprising recombinant adeno-associated virus for use in the treatment in humans of gene therapy treatable diseases, namely, osteoarthritis, neurologic conditions, inflammatory conditions, immune-mediated conditions, endocrine diseases, chronic degenerative diseases, gastrointestinal diseases; Pharmaceutical preparations comprising recombinant adeno-associated virus for the treatment in humans of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the ocular and auditory systems, and the genitourinary system. , Pharmaceutical preparations comprising recombinant adeno-associated virus for use in gene therapy for the treatment in humans of osteoarthritis, neurologic conditions, inflammatory conditions, immune-mediated conditions, endocrine diseases, chronic degenerative diseases, gastrointestinal diseases; Pharmaceutical preparations comprising recombinant adeno-associated virus for gene therapy for the treatment in humans of genetic diseases or disorders; Pharmaceutical preparations comprising recombinant adeno-associated virus for use in the treatment in humans of gene therapy treatable diseases, namely, osteoarthritis, neurologic conditions, inflammatory conditions, immune-mediated conditions, endocrine diseases, chronic degenerative diseases, gastrointestinal diseases; Pharmaceutical preparations comprising recombinant adeno-associated virus for the treatment in humans of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the ocular and auditory systems, and the genitourinary system. .

Get FREE email alerts

100% Satisfaction Guarantee

protect your valuable brand now.

Classification Information

Class Code:	005 - Pharmaceutical Products
Description:	Pharmaceuticals and herbicides

Matter History Events

Status Date	Record Status Description
2023-02-27	National prosecution history entry - Amendment to Registration
2019-08-13	Registration published - Registered
2019-07-17	Application published - Registration Pending
2019-07-17	National prosecution history entry - Registration Fee Notice Sent
2019-04-24	Application published - Advertised
2019-03-15	National prosecution history entry - Note to file
2019-03-07	Application accepted - Approved
2019-01-18	National prosecution history entry - Approval Notice Sent
2018-12-14	National prosecution history entry - Rep for Service Changed
2018-12-14	National prosecution history entry - Agent Changed
2018-09-06	National prosecution history entry - Extension of Time
2018-02-28	National prosecution history entry - Correspondence Created
2017-08-24	National prosecution history entry - Extension of Time
2017-02-21	National prosecution history entry - Search Recorded
2017-02-21	National prosecution history entry - Examiner's First Report
2016-08-01	Filing date accorded - Formalized
2016-07-26	National prosecution history entry - Created
2016-07-25	Application filed - Filed

Word Mark:	ADVERUM
Current Status:	Registration published LIVE Mark! 8/13/2019
Application Number:	1793092
Filing Date:	Monday, July 25, 2016
Filing Place:	Canada
Registration Date:	Tuesday, August 13, 2019
Registration Number:	TMA1048618
Register Type:	Primary
Type Of Mark:	Trademark
Mark Feature:	Word
Use In Commerce:	No
Publication Registration:	Wednesday, April 24, 2019
Opposition:	4/24/2019 - 4/24/2019
Last Applicant/Owner:	ADVERUM BIOTECHNOLOGIES, INC., ******* ****** * **
Correspondent:	Not provided

Goods and Services Information
Description:	(1) - Pharmaceutical preparations comprising recombinant adeno-associated virus for use in gene therapy for the treatment in humans of osteoarthritis, neurologic conditions, inflammatory conditions, immune-mediated conditions, endocrine diseases, chronic degenerative diseases, gastrointestinal diseases; Pharmaceutical preparations comprising recombinant adeno-associated virus for gene therapy for the treatment in humans of genetic diseases or disorders; Pharmaceutical preparations comprising recombinant adeno-associated virus for use in the treatment in humans of gene therapy treatable diseases, namely, osteoarthritis, neurologic conditions, inflammatory conditions, immune-mediated conditions, endocrine diseases, chronic degenerative diseases, gastrointestinal diseases; Pharmaceutical preparations comprising recombinant adeno-associated virus for the treatment in humans of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the ocular and auditory systems, and the genitourinary system. (2) - Pharmaceutical preparations including pharmaceutical preparations for the treatment of diseases or disorders. (3) - Pharmaceutical preparations for use in gene therapy for the treatment in humans of osteoarthritis, neurologic conditions, inflammatory conditions, immune-mediated conditions, endocrine diseases, chronic degenerative diseases, gastrointestinal diseases; Pharmaceutical preparations for gene therapy for the treatment in humans of genetic diseases or disorders; Pharmaceutical preparations for use in the treatment in humans of gene therapy treatable diseases, namely, osteoarthritis, neurologic conditions, inflammatory conditions, immune-mediated conditions, endocrine diseases, chronic degenerative diseases, gastrointestinal diseases; pharmaceutical preparations for the treatment in humans of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the ocular and auditory systems, and the genitourinary system. (4) - Pharmaceutical preparations for use in gene therapy for the treatment in humans of osteoarthritis, neurologic conditions, inflammatory conditions, immune-mediated conditions, endocrine diseases, chronic degenerative diseases, gastrointestinal diseases; Pharmaceutical preparations for gene therapy for the treatment in humans of genetic diseases or disorders; Pharmaceutical preparations for use in the treatment in humans of gene therapy treatable diseases, namely, osteoarthritis, neurologic conditions, inflammatory conditions, immune-mediated conditions, endocrine diseases, chronic degenerative diseases, gastrointestinal diseases; pharmaceutical preparations for the treatment in humans of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the ocular and auditory systems, and the genitourinary system. (5) - Pharmaceutical preparations including pharmaceutical preparations for the treatment of diseases or disorders. (6) - Pharmaceutical preparations comprising recombinant adeno-associated virus for use in gene therapy for the treatment in humans of osteoarthritis, neurologic conditions, inflammatory conditions, immune-mediated conditions, endocrine diseases, chronic degenerative diseases, gastrointestinal diseases; Pharmaceutical preparations comprising recombinant adeno-associated virus for gene therapy for the treatment in humans of genetic diseases or disorders; Pharmaceutical preparations comprising recombinant adeno-associated virus for use in the treatment in humans of gene therapy treatable diseases, namely, osteoarthritis, neurologic conditions, inflammatory conditions, immune-mediated conditions, endocrine diseases, chronic degenerative diseases, gastrointestinal diseases; Pharmaceutical preparations comprising recombinant adeno-associated virus for the treatment in humans of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the ocular and auditory systems, and the genitourinary system. (7) - Pharmaceutical preparations comprising recombinant adeno-associated virus for use in gene therapy for the treatment in humans of osteoarthritis, neurologic conditions, inflammatory conditions, immune-mediated conditions, endocrine diseases, chronic degenerative diseases, gastrointestinal diseases; Pharmaceutical preparations comprising recombinant adeno-associated virus for gene therapy for the treatment in humans of genetic diseases or disorders; Pharmaceutical preparations comprising recombinant adeno-associated virus for use in the treatment in humans of gene therapy treatable diseases, namely, osteoarthritis, neurologic conditions, inflammatory conditions, immune-mediated conditions, endocrine diseases, chronic degenerative diseases, gastrointestinal diseases; Pharmaceutical preparations comprising recombinant adeno-associated virus for the treatment in humans of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the ocular and auditory systems, and the genitourinary system. (8) - Pharmaceutical preparations comprising recombinant adeno-associated virus for use in gene therapy for the treatment in humans of osteoarthritis, neurologic conditions, inflammatory conditions, immune-mediated conditions, endocrine diseases, chronic degenerative diseases, gastrointestinal diseases; Pharmaceutical preparations comprising recombinant adeno-associated virus for gene therapy for the treatment in humans of genetic diseases or disorders; Pharmaceutical preparations comprising recombinant adeno-associated virus for use in the treatment in humans of gene therapy treatable diseases, namely, osteoarthritis, neurologic conditions, inflammatory conditions, immune-mediated conditions, endocrine diseases, chronic degenerative diseases, gastrointestinal diseases; Pharmaceutical preparations comprising recombinant adeno-associated virus for the treatment in humans of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the ocular and auditory systems, and the genitourinary system.

Perfect for these industries

Words that describe this mark

a canadian trademark registration was filed for by . The Canadian IP office has given the trademark application number of . The current status of this trademark filing is . The correspondent listed for is The trademark is filed in the description of .

Trademarkia is the largest search engine for U.S., China, European Union, Canada, and Australia Trademarks. Each month hundreds of trademarks around the world are filed by licensed attorneys in the Trademarkia network law firms! You can register your trademark in 180+ countries in the world through Trademarkia Network. Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.

100% Satisfaction Guarantee

protect your valuable brand now.

How it works

1. Trademarkia Network Law firm - #1 Trademark Filing since 2010.

2. Describe how your business or product is being used. Register your mark in 180+ countries.

What you get

1. Top Global Specialist - Credibility and Experience!

2. All processes will be performed in a timely manner. You will be informed periodically about the process.

What our customers say:

I wasn't too sure what to expect when taking up services, but the professionalism from the site to the customer service is the slickest I have ever experienced.

Camryn, Surrey, UK

How it works

1. Trademarkia Network Law firm - #1 Trademark Filing since 2010.

2. Describe how your business or product is being used. Register your mark in 180+ countries.

What you get

1. Top Global Specialist - Credibility and Experience!

2. All processes will be performed in a timely manner. You will be informed periodically about the process.

What our customers say:

I wasn't too sure what to expect when taking up services, but the professionalism from the site to the customer service is the slickest I have ever experienced.

Camryn, Surrey, UK

What You Can Do:

Start Your Business

Get FREE email alerts

Add to Favorites

Start Canada Trademark Filing

Custom Logo Design $99

Search on popular social networks

Trademarkia lets you see how your personal name, product name, trademark name or username is being used on any of 530+ new and popular social networks. Be the first to reserve your name and get help stopping others from using it - all in one place!

As seen on